Skip to Content

'
Linda S Elting, Dr P H

Present Title & Affiliation

Primary Appointment

Professor, Department of Health Services Research, Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX

Dual/Joint/Adjunct Appointment

Associate Member, The University of Texas Graduate School of Biomedical Sciences, Houston, TX
Professor, Department of Health Disparities Research, Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX

Education & Training

Degree-Granting Education

1988 The University of Texas School of Public Health, Houston, TX, DrPH, Epidemiology, Biometry, Infectious Diseases
1981 The University of Texas School of Public Health, Houston, TX, MPH, Disease Control
1974 Houston Baptist University, Houston, TX, BS, Nursing

Board Certifications

1/1986 Association of Practitioners in Infection Control - Certified in Infection Control

Experience/Service

Academic Appointments

Professor, Department of Biostatistics, Division of Quantitative Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, 2004-2013
Associate Professor, Department of Biostatistics and Applied Mathematics, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 2001-2004
Research Assistant, Research Nurse Supervisor, Project Coordinator, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 1976-1988
Staff Nurse, Hermann Hospital, Houston, TX, 1975-1976
Health Educator, Harris County Center for the Retarded, Adult Residential Facility, Houston, TX, 1974-1975
Coding and Data Collection, Department of Epidemiology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, 1970-1971

Administrative Appointments/Responsibilities

Vice-Chairman, Institutional Review Board IV, The University of Texas MD Anderson Cancer Center, Houston, TX, 2/2014-present
Chairman, Institutional Review Board IV, The University of Texas MD Anderson Cancer Center, Houston, TX, 9/2005-1/2014
Vice-Chairman, Institutional Review Board, The University of Texas MD Anderson Cancer Center, Houston, TX, 9/2003-8/2005
Chief, Section of Health Services Research, Department of Biostatistics & Applied Mathematics, The University of Texas MD Anderson Cancer Center, Houston, TX, 6/2001-present
Director of Research, Section of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 1/1998-1/1999
Director, Clinical Epidemiology and Informatics, Ambulatory & Supportive Care Oncology Research Program, The University of Texas MD Anderson Cancer Center, Houston, TX, 1/1992-1/1998

Other Appointments/Responsibilities

Design, Patient Satisfaction Survey for the Ambulatory Treatment Center and General Internal Medicine Clinics, Houston, 1/1997-1/1999
Design and Management, Ambulatory Treatment Center and General Internal Medicine Information Systems, Houston, 1/1994-1/1999

Institutional Committee Activities

Vice-Chairman, Institutional Review Board 4, 2014-present
Member, Data and Prioritization Committee for Comprehensive Cancer Control, 12/2008-present
Member, Comprehensive Cancer Strategic Plan Steering Committee, 9/2008-present
Chairman, Institutional Review Board 4, 9/2005-2014
Member, Biostatistics Faculty Search Committee, 1/2004-1/2005
Vice-Chairman, Institution Review Board, 9/2003-9/2005
Member, Education Subcommittee for Faculty Achievement Awards, 9/2003-12/2003
Chairman, IRB Task force to develop standard operating procedures for members conflicts of interest, 8/2003-1/2004
Member, Search Committee, Department of Health Disparities Research, 1/2003-1/2004
Member, Department of Epidemiology Faculty Search Committee, 1/2003-1/2004
Member, Center for Research in Minority Health, Internal Advisory Board, 1/2002-present
Member, Search Committee, Head, Division of Internal Medicine, 1/2001-1/2002
Chairman, Economist Faculty Search Committee, 1/2001-1/2002
Member, Prostate Outcomes Faculty Search Committee, UT M.D Anderson Cancer Center, 1/2001-1/2002
Member, Cancer Prevention Subcommittee for the Faculty Achievement Awards, 1/2001-12/2001
Faculty Senate Representative, Employee Satisfaction Steering Committee, 1/2000-1/2002
Member, Faculty Senate, 1/1999-1/2002
Member, Faculty Senate - Research Affairs Committee, 1/1999-1/2002
Member, Study Section Review Committee for Clinical, Translational and Population-Based Research Projects, 1/1999-1/2002
Member, Division of Medicine, Executive Council - Research Sub-Committee, 1/1999-12/1999
Member, Surveillance Committee (Institutional Review Board), 9/1997-present
Co-Chairman, Psychosocial, Behavioral and Health Services Research Review Committee, 9/1997-1/2001
Member, Health Services Research Working Group, 1/1994-1/1998
Chairman, Quality of Life Steering Committee, 1/1994-1/1995

Honors and Awards

2012 Texas Business Women's Award, Texas Business Women Inc.
2011-present Senior Fellow, Sealy Center on Aging, The University of Texas Medical Branch
2011 MASCC Distinguished Achievement Award, Multinational Association of Supportive Care in Cancer
2006 Outstanding Research Presentation, Texas Public Health Association Annual Meeting
2005 Best Research Presentation, Texas Public Health Association Annual Meeting
2003 Best Research Presentation, Texas Public Health Association Annual Meeting
2001 Best Research Presentation, Kelsey Research Foundation Health Services and Outcomes Research Conference
2000 Selected to attend Senior Women in Medicine Professional Development Seminar, Association of American Medical Colleges
1997 Best Proffered Paper Award, Annual Meeting, Multinational Association for Supportive Care in Cancer

Selected Publications

Peer-Reviewed Original Research Articles

1. Elting L, Chang YC. Costs of oral complications of emerging cancer therapies: Current estimates and a blueprint for future study. JNCI. In Press.
2. Keefe DM, Elting LS, Nguyen HT, Grunberg SM, Aprile G, Bonaventura A, Selva-Nayagam S, Barsevick A, Koczwara B, Sonis ST. Risk and outcomes of chemotherapy-induced diarrhea (CID) among patients with colorectal cancer receiving multi-cycle chemotherapy. Cancer Chemother Pharmacol. e-Pub 7/25/2014. PMID: 25055935.
3. Barcenas CH, Niu J, Zhang N, Zhang Y, Buchholz TA, Elting LS, Hortobagyi GN, Smith BD, Giordano SH. Risk of Hospitalization According to Chemotherapy Regimen in Early-Stage Breast Cancer. J Clin Oncol 32(19):2010-7, 7/1/2014. e-Pub 5/27/2014. PMID: 24868022.
4. Eberth JM, Xu Y, Smith GL, Shen Y, Jiang J, Buchholz TA, Hunt KK, Black DM, Giordano SH, Whitman GJ, Yang W, Shen C, Elting L, Smith BD. Surgeon influence on use of needle biopsy in patients with breast cancer: a national medicare study. J Clin Oncol 32(21):2206-16, 7/20/2014. e-Pub 6/9/2014. PMID: 24912900.
5. Guadagnolo BA, Liao KP, Giordano SH, Elting LS, Buchholz TA, Shih YC. Increasing Use of Advanced Radiation Therapy Technologies in the Last 30 Days of Life Among Patients Dying As a Result of Cancer in the United States. J Oncol Pract 10(4):e269-76, 7/2014. e-Pub 4/22/2014. PMID: 24756144.
6. Holmes HM, Nguyen HT, Nayak P, Oh JH, Escalante CP, Elting LS. Chronic Conditions and Health Status in Older Cancer Survivors. Eur J Intern Med 25(4):374-8, 4/2014. e-Pub 1/2/2014. PMID: 24389373.
7. Sabir SH, Armstrong R, Elting LS, Wallace MJ, Gupta S, Tam AL. Early initiation of enteral feeding in cancer patients after outpatient percutaneous fluoroscopy-guided gastrostomy catheter placement. J Vasc Interv Radiol 25(4):618-22, 4/2014. PMID: 24674218.
8. Beadle BM, Liao KP, Elting LS, Buchholz TA, Ang KK, Garden AS, Guadagnolo BA. Improved survival using intensity-modulated radiation therapy in head and neck cancers: A SEER-Medicare analysis. Cancer 120(5):702-10, 3/1/2014. e-Pub 1/13/2014. PMID: 24421077.
9. Suarez-Almazor ME, Peddi P, Luo R, Nguyen HT, Elting LS. Low Rates of Bone Mineral Density Measurement in Medicare Beneficiaries with Prostate Cancer Initiating Androgen Deprivation Therapy. Support Care Cancer 22(2):537-44, 2/2014. e-Pub 10/22/2013. PMID: 24146343.
10. Mawardi H, Manlove AE, Elting LS, Marty FM, Treister NS, Woo SB. Cost analysis of dental services needed before hematopoietic cell transplantation. Oral Surg Oral Med Oral Pathol Oral Radiol 117(1):59-66, 1/2014. PMID: 24332328.
11. Beadle BM, Liao KP, Chambers MS, Elting LS, Buchholz TA, Kian Ang K, Garden AS, Guadagnolo BA. Evaluating the impact of patient, tumor, and treatment characteristics on the development of jaw complications in patients treated for oral cancers: A SEER-Medicare analysis. Head Neck 35(11):1599-605, 11/2013. e-Pub 11/14/2012. PMID: 23150453.
12. Elting LS, Chang YC, Parelkar P, Boers-Doets CB, Michelet M, Hita G, Rouleau T, Cooksley C, Halm J, Vithala M, Bossi P, Escalante C, Brennan MT, Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO). Risk of oral and gastrointestinal mucosal injury among patients receiving selected targeted agents: a meta-analysis. Support Care Cancer 21(11):3243-3254, 11/2013. e-Pub 5/2/2013. PMID: 23636648.
13. Ost DE, Niu J, Elting L, Buchholz TA, Giordano SH. Quality Gaps and Comparative Effectiveness in Lung Cancer Staging and Diagnosis. Chest. e-Pub 10/3/2013. PMID: 24091637.
14. Avritscher EB, Cooksley CD, Rolston KV, Swint JM, Delclos GL, Franzini L, Swisher SG, Walsh GL, Mansfield PF, Elting LS. Serious Postoperative Infections Following Resection of Common Solid Tumors: Outcomes, Costs, and Impact of Hospital Surgical Volume. Support Care Cancer. e-Pub 10/19/2013. PMID: 24141699.
15. Chavez-Macgregor M, Zhang N, Buchholz TA, Zhang Y, Niu J, Elting L, Smith BD, Hortobagyi GN, Giordano SH. Trastuzumab-Related Cardiotoxicity Among Older Patients With Breast Cancer. J Clin Oncol. e-Pub 10/14/2013. PMID: 24127446.
16. Eberth JM, Eschbach K, Morris JS, Nguyen HT, Hossain MM, Elting LS. Geographic disparities in mammography capacity in the South: a longitudinal assessment of supply and demand. Health Serv Res. e-Pub 7/5/2013. PMID: 23829179.
17. Gomez DR, Liao KP, Giordano S, Nguyen H, Smith BD, Elting LS. Adherence to national guidelines for antiemesis prophylaxis in patients undergoing chemotherapy for lung cancer: a population-based study. Cancer 119(7):1428-36, 4/1/2013. e-Pub 12/4/2012. PMID: 23212885.
18. Freeman J, Elting L. Training Core- Principal Investigators. Texas Public Health Journal 65(2):25, 4/2013.
19. Tan A, Kuo YF, Elting LS, Goodwin JS. Refining physician quality indicators for screening mammography in older women: distinguishing appropriate use from overuse. J Am Geriatr Soc 61(3):380-7, 3/2013. e-Pub 3/2013. PMCID: PMC3602404.
20. Guadagnolo BA, Liao KP, Elting L, Giordano S, Buchholz TA, Shih YC. Use of radiation therapy in the last 30 days of life among a large population-based cohort of elderly patients in the United States. J Clin Oncol 31(1):80-7, 1/1/2013. e-Pub 11/19/2012. PMCID: PMC3530693.
21. Parelkar PP, Hoang NT, Holmes H, Elting L. Adherence to physical activity guidelines after cancer diagnosis among cancer survivors ages 45-64 in Texas. Texas Public Health Journal 65(1):32, 1/2013.
22. Eberth JM, Prarelkar P, Nguyen H, Sun C, Irvin-Vidrine J, Elting LS. The Human and Economic Burden of Cervical Cancer in Texas. Tex Public Health J 65(2):51, 1/2013. PMCID: PMC3898737.
23. Holmes HM, Luo R, Hanlon JT, Elting LS, Suarez-Almazor M, Goodwin JS. Ethnic Disparities in Adherence to Antihypertensive Medications of Medicare Part D Beneficiaries. J Am Geriatr Soc 60(7):1298-303, 7/2012. e-Pub 6/2012. PMCID: PMC3396714.
24. Shih YC, Ward JF, Pettaway CA, Xu Y, Matin SF, Davis JW, Thompson BP, Elting LS. Comparative effectiveness, cost, and utilization of radical prostatectomy among young men within managed care insurance plans. Value Health 15(2):367-75, Mar-Apr, 3/2012. e-Pub 12/16/2011. PMID: 22433769.
25. Vissink A, Mitchell JB, Baum BJ, Limesand KH, Jensen SB, Fox PC, Elting LS, Langendijk JA, Coppes RP, Reyland ME. Clinical management of salivary gland hypofunction and xerostomia in head-and-neck cancer patients: successes and barriers. Int J Radiat Oncol Biol Phys 78(4):983-91, 11/15/2010. PMCID: PMC2964345.
26. Avritscher EB, Shih YC, Sun CC, Gralla RJ, Grunberg SM, Xu Y, Elting LS. Cost-Utility Analysis of Palonosetron-Based Therapy in Preventing Emesis Among Breast Cancer Patients. J Support Oncol 8(6):242-251, Nov-Dec, 11/2010. PMID: 21265391.
27. Jones JA, Fayad LE, Elting LS, Rodriguez MA. Body mass index and outcomes in patients receiving chemotherapy for intermediate-grade B-cell non-Hodgkin lymphoma. Leuk Lymphoma 51(9):1649-57, 9/2010. PMID: 20807093.
28. Migliorati CA, Woo SB, Hewson I, Barasch A, Elting LS, Spijkervet FK, Brennan MT, Bisphosphonate Osteonecrosis Section, Oral Care Study Group, Multinational Association of Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO). A systematic review of bisphosphonate osteonecrosis (BON) in cancer. Support Care Cancer 18(8):1099-106, 8/2010. e-Pub 4/22/2010. PMID: 20411279.
29. Hong CH, Napeñas JJ, Hodgson BD, Stokman MA, Mathers-Stauffer V, Elting LS, Spijkervet FK, Brennan MT, Dental Disease Section, Oral Care Study Group, Multi-national Association of Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO). A systematic review of dental disease in patients undergoing cancer therapy. Support Care Cancer 18(8):1007-21, 8/2010. e-Pub 5/7/2010. PMCID: PMC2914291.
30. Hovan AJ, Williams PM, Stevenson-Moore P, Wahlin YB, Ohrn KE, Elting LS, Spijkervet FK, Brennan MT, Dysgeusia Section, Oral Care Study Group, Multinational Association of Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO). A systematic review of dysgeusia induced by cancer therapies. Support Care Cancer 18(8):1081-7, 8/2010. e-Pub 5/2010. PMID: 20495984.
31. Lalla RV, Latortue MC, Hong CH, Ariyawardana A, D'Amato-Palumbo S, Fischer DJ, Martof A, Nicolatou-Galitis O, Patton LL, Elting LS, Spijkervet FK, Brennan MT, Fungal Infections Section, Oral Care Study Group, Multinational Association of Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO). A systematic review of oral fungal infections in patients receiving cancer therapy. Support Care Cancer 18(8):985-92, 8/2010. e-Pub 5/8/2010. PMCID: PMC2914797.
32. Epstein JB, Hong C, Logan RM, Barasch A, Gordon SM, Oberlee-Edwards L, McGuire D, Napenas JJ, Elting LS, Spijkervet FK, Brennan MT. A systematic review of orofacial pain in patients receiving cancer therapy. Support Care Cancer 18(8):1023-31, 8/2010. e-Pub 6/11/2010. PMID: 20544225.
33. Jensen SB, Pedersen AM, Vissink A, Andersen E, Brown CG, Davies AN, Dutilh J, Fulton JS, Jankovic L, Lopes NN, Mello AL, Muniz LV, Murdoch-Kinch CA, Nair RG, Napeñas JJ, Nogueira-Rodrigues A, Saunders D, Stirling B, von Bültzingslöwen I, Weikel DS, Elting LS, Spijkervet FK, Brennan MT, Salivary Gland Hypofunction/Xerostomia Section, Oral Care Study Group, Multinational Association of Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO). A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: management strategies and economic impact. Support Care Cancer 18(8):1061-79, 8/2010. e-Pub 3/25/2010. PMID: 20333412.
34. Jensen SB, Pedersen AM, Vissink A, Andersen E, Brown CG, Davies AN, Dutilh J, Fulton JS, Jankovic L, Lopes NN, Mello AL, Muniz LV, Murdoch-Kinch CA, Nair RG, Napeñas JJ, Nogueira-Rodrigues A, Saunders D, Stirling B, von Bültzingslöwen I, Weikel DS, Elting LS, Spijkervet FK, Brennan MT, Salivary Gland Hypofunction/Xerostomia Section, Oral Care Study Group, Multinational Association of Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO). A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life. Support Care Cancer 18(8):1039-60, 8/2010. e-Pub 3/17/2010. PMID: 20237805.
35. Bensadoun RJ, Riesenbeck D, Lockhart PB, Elting LS, Spijkervet FK, Brennan MT, Trismus Section, Oral Care Study Group, Multinational Association for Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO). A systematic review of trismus induced by cancer therapies in head and neck cancer patients. Support Care Cancer 18(8):1033-8, 8/2010. e-Pub 3/6/2010. PMID: 20213237.
36. Elad S, Zadik Y, Hewson I, Hovan A, Correa ME, Logan R, Elting LS, Spijkervet FK, Brennan MT, Viral Infections Section, Oral Care Study Group, Multinational Association of Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO). A systematic review of viral infections associated with oral involvement in cancer patients: a spotlight on Herpesviridea. Support Care Cancer 18(8):993-1006, 8/2010. e-Pub 6/11/2010. PMID: 20544224.
37. Peterson DE, Doerr W, Hovan A, Pinto A, Saunders D, Elting LS, Spijkervet FK, Brennan MT. Osteoradionecrosis in cancer patients: the evidence base for treatment-dependent frequency, current management strategies, and future studies. Support Care Cancer 18(8):1089-98, 8/2010. e-Pub 6/6/2010. PMID: 20526784.
38. Brennan MT, Spijkervet FK, Elting LS. Systematic reviews and guidelines for oral complications of cancer therapies: current challenges and future opportunities. Support Care Cancer 18(8):977-8, 8/2010. e-Pub 3/10/2010. PMID: 20217147.
39. Brennan MT, Elting LS, Spijkervet FK. Systematic reviews of oral complications from cancer therapies, oral care study group, MASCC/ISOO: Methodology and Quality of the Literature. Support Care Cancer 18(8):979-84, 8/2010. e-Pub 3/2010. PMID: 20306090.
40. Shih YCT, Elting LS, Halpern MT. Factors associated with immunotherapy use among newly diagnosed cancer patients. Medical Care 47(9):948-58, 1/2010.
41. Shih YC, Elting LS, Pavluck AL, Stewart A, Halpern MT. Immunotherapy in the initial treatment of newly diagnosed cancer patients: utilization trend and cost projections for non-Hodgkin's lymphoma, metastatic breast cancer, and metastatic colorectal cancer. Cancer Invest 28(1):46-53, 1/2010. PMID: 19995227.

Invited Articles

1. Svatek RS, Avritscher EB, Elting L, Dinney CP. High Risk Populations and Cystectomy Outcomes. J Urol. e-Pub 5/2009. PMID: 19450857.
2. Bensinger W, Schubert M, Ang KK, Brizel D, Brown E, Eilers JG, Elting L, Mittal BB, Schattner MA, Spielberger R, Treister NS, Trotti AM. NCCN Task Force Report. prevention and management of mucositis in cancer care. J Natl Compr Canc Netw 6(Suppl 1):S1-21; quiz S22-4, 1/2008. PMID: 18289497.
3. Elting LS. Annual Meeting Summaries: Health Services Research Abstracts. American Society of Clinical Oncology:117-123, 2005.
4. Elting LS, Keefe DMK, Sonis ST. Treatment-induced Gastrointestinal Toxicity in Patients with Cancer. American Society of Clinical Oncology, 2004 Educational Book, 2004.
5. Rubenstein EB, Elting LS. Pharmacoeconomic analyses: whose perspective counts and costs the most? Am J Hosp Pharm 51(12):1564-9, 6/1994. PMID: 8092157.

Abstracts

1. Suarez-Almazor, ME, Peddi P, Luo R, Nguyen H, Elting L. Low Rates of Bone Mineral Density Measurement in Men with Prostate Cancer Initiating Androgen Deprivation Therapy: A Population-Based Study of Medicare Beneficiaries in the State of Texas. ASCO's Quality Care Symposium: Quality Matters, San Diego, CA, 2012.
2. Elting L, Nguyen H, Irvin Vidrine J, Freedman R, Theriault R. Health Behaviors and Health Status of Cancer Survivors in Texas: A Statewide Study. Cancer Survivorship Research Symposium, UT MD Anderson Cancer Center, Houston, Texas, 1/2011.
3. Elting L On Behalf Of Cercit Investigators, Xu Y, Nguyen H. Adherence to National Guidelines for Prophylactic Use of Granuloctye Growth Factors among Elderly Texans with Non-Hodgkin's Lymphoma. Innovations In Cancer Prevention and Research Conference, Austin, TX, 2011.
4. Gomez D, Liao K, Nguyen H, Smith B, Elting L On Behalf of Cercit Investigators. An estimation of guideline adherence to nausea and vomiting prophylaxix in patients receiving systemic therapy for lung cancer. Innovations In Cancer Prevention and Research Conference, Austin, TX, 2011.
5. Suarez-Almazor M, Luo R, Nguyen H, Elting L On Behalf of Cercit Investigators. Measurement of Bone Mineral Density in Patients with Breast Cancer Initiating therapy with Aromatase Inhibitors: Low Utilization and Ethnic Disparities. Innovations In Cancer Prevention and Research Conference, Austin, TX, 2011.
6. Parelkar P, Nguyen H, Elting E On Behalf of Cercit Investigators. Physical Inactivity Among Cancer Survivors Age 45-65 in Texas. Innovations In Cancer Prevention and Research Conference, Austin, TX, 2011.
7. Nguyen H, Elting L On Behalf of Cercit Investigators. Prevalence and Association of Health Behaviors and Cardiovascular Diseases among Adult Survivors of Childhood Cancer in the U S Population. Innovations In Cancer Prevention and Research Conference, Austin, TX, 2011.
8. Elting L, Lei X, Nguyen H, Keefe D, Sonis S. Risk of Patient-Reported Oral Mucositis During Chemotherapy For Colorectal Cancer (CRC): Do Multiple Cycles Multiply Risks?. Supportive Care in Cancer 19(Suppl 2: S67-S370):S215, 2011.
9. Holmes H, Nguyen H, Oh J, Escalante C, Vidrine J, Freedman R, Theriault R, Wetter L, Elting L On Behalf of Cercit Investigators. The Burden of Comorbid Illness in Cancer Survivors. Innovations In Cancer Prevention and Research Conference, Austin, TX, 2011.
10. Nguyen HT, Vidrine JI, Freedman RS, Theriault RL, Wetter DW, Elting LS. The Burden of Comorbid Illness in Cancer Survivors in the United States. Supportive Care in Cancer 19(Suppl 2:S67-S370):196-7, 2011.

Book Chapters

1. Avritsher EBC, Parelkar P, Chang YC, Elting LS. Quality of Life and Economic Outcomes of Nausea and Vomiting. In: Nausea: A practical guide to clinical management. Cambridge University Press. In Press.
2. Elting LS, Chang YC, Parelkar P. Epidemiology and Outcomes of Regimen-Related Toxicities. In: Pathobiology of Cancer Regimen-Related Toxicities. Springer, 3-18, 2013.
3. Elting LS, Paesmans M. Controversies and Quandries: The Design of Clinical Trials in Febrile Neutropenia. IN: Rubenstein EB and Rolston KVI, Eds. In: Fever in the Neutropenic Cancer Patient. Martin Dunitz, Ltd., 45-55, 2001.
4. Rubenstein EB, Elting LS, Sun CC, Rolston KVI. Outpatient management of neutropenic fever: Antibiotics, growth factors or both? IN: Wingard J, Demetri G, Eds. In: Clinical Applications of Cytokines and Growth Factors. Kluwer Academic Publishers, 159-177, 1999.

Letters to the Editor

1. Elting LS, Cantor SB. Author Reply. The Burdens of Cancer Therapy: Clinical and Economic Outcomes of Chemotherapy-Induced Mucositis. Cancer 100:1325-1326, 2004.
2. Rolston KV, Elting LS, Bodey GP. Bacteremia due to viridans streptococci in neutropenic patients. Am J Med 99(4):450, 1995. PMID: 7573114.
3. Rubenstein EB, Elting LS. Re-examination of clinical aspects of pharmacoeconomic analysis. Am J Hosp Pharm 51(23):2970-3, 12/1/1994. PMID: 7879813.
4. Rubenstein EB, Elting LS. Re-examination of clinical aspects in pharmacoeconomic analysis. Am J Hosp Pharm 51(23):2970-3, 12/1994. PMID: 7879813.
5. Rubenstein EB, Rolston K, Elting L. Outpatient antibiotic therapy in febrile neutropenic patients undergoing high-dose chemotherapy and autologous bone marrow support. J Clin Oncol 12(11):2516-1517, 11/1994. PMID: 7964970.
6. Rubenstein EB, Rolston K, Benjamin RS, Loewy J, Escalante C, Manzullo E, Hughes P, Moreland B, Fender A, Kennedy K. Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer. Cancer 71(11):3640-6, 6/1993. PMID: 8490912.

Grant & Contract Support

Title: Methods Training in Patient-Centered Cancer Outcomes Research
Funding Source: Agency for Healthcare Research and Quality (AHRQ)
Role: Co-Investigator
Principal Investigator: Suarez-Almazor
Duration: 6/1/2014 - 5/31/2019
 
Title: Smoking Cessation for Cervical Cancer Survivors in a Safety Net Healthcare System
Funding Source: NIH/NCI
Role: Co-Investigator
Principal Investigator: Irvin-Vidrine
Duration: 5/12/2014 - 4/30/2019
 
Title: CERCIT: Comparative Effectiveness Research on Cancer in Texas (C2: Training Core)
Funding Source: Cancer Prevention & Research Institute of Texas (CPRIT) Subcontract from UTMB
Role: Co-Investigator
Principal Investigator: Goodwin
Duration: 3/1/2014 - 2/29/2016
 
Title: CERCIT: Comparative Effectiveness Research on Cancer in Texas (P4: Quality of Supportive Cancer Care in Texas)
Funding Source: Cancer Prevention & Research Institute of Texas (CPRIT)
Role: Principal Investigator-MDACC
Principal Investigator: Goodwin
Duration: 3/1/2014 - 2/29/2016
 
Title: Using Claims Data to Evaluate Radiation Therapy Utilization at the End of Life
Funding Source: NIH/NCI
Role: Co-Investigator
Principal Investigator: Ashleigh Guadagnolo
Duration: 9/6/2012 - 8/31/2014
 
Title: Cost-of-Illness of Chemotherapy-induced Diarrhea in Cancer Patients
Funding Source: TRIAD Burden of Illness, Inc.
Role: Principal Investigator
Duration: 11/8/2010 - 11/30/2014

Last updated: 8/11/2014